NuCana plc Sponsored ADR Stock
NuCana plc Sponsored ADR Stock price
Key metrics
| Market capitalization | $2.83m |
| Enterprise Value | $-11.52m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | 0.55 |
| P/B ratio (TTM) P/B ratio | 0.59 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-42.31m |
| Free Cash Flow (TTM) Free Cash Flow | $-20.98m |
| Cash position | $14.71m |
Is NuCana plc Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
NuCana plc Sponsored ADR Stock Analysis
Analyst Opinions
3 Analysts have issued a NuCana plc Sponsored ADR forecast:
Analyst Opinions
3 Analysts have issued a NuCana plc Sponsored ADR forecast:
Financial data from NuCana plc Sponsored ADR
| Jun '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -0.70 -0.70 |
6%
6%
|
|
| EBITDA | -42 -42 |
7%
7%
|
EBIT (Operating Income) EBIT | -42 -42 |
7%
7%
|
| Net Profit | -35 -35 |
10%
10%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about NuCana plc Sponsored ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
NuCana plc Sponsored ADR Stock News
Company Profile
NuCana Plc engages in the development of technology platform for the treatment of patients with cancer. Its Protide technology consists of acelarin, NUC-3373 and NUC-7738. The company was founded by Hugh S. Griffith and Christopher B. Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.
| Head office | United Kingdom |
| CEO | Hugh Griffith |
| Employees | 28 |
| Founded | 1997 |
| Website | www.nucana.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
